Bausch Health Companies (BHC) Curent Deferred Tax Liability (2010 - 2015)
Bausch Health Companies (BHC) reported Curent Deferred Tax Liability of $11.6 million for Q3 2015, down 38.95% on a YoY basis from $19.0 million in Q3 2014, and down 69.63% sequentially from $38.2 million in Q2 2015.
Bausch Health Companies (BHC) Curent Deferred Tax Liability (2010 - 2015) Analysis & Trends
Bausch Health Companies (BHC) has 6 years of Curent Deferred Tax Liability data on file, last reported at $11.6 million in Q3 2015.
- For the quarter ending Q3 2015, Curent Deferred Tax Liability fell 38.95% year-over-year to $11.6 million; the trailing twelve-month figure through Sep 2015 stood at $11.6 million (down 38.95% YoY), and the FY2014 full-year result was $10.7 million, down 83.79% from the prior year.
- Curent Deferred Tax Liability eased to $11.6 million in Q3 2015, from $38.2 million in the prior quarter.
- In the past five years, Curent Deferred Tax Liability ranged from a high of $66.0 million in Q4 2013 to a low of $1.9 million in Q1 2011.
- A 5-year average of $15.5 million and a median of $8.2 million in 2012 frame the typical range for Curent Deferred Tax Liability.
- Across the five-year window, Curent Deferred Tax Liability soared 1398.98% in 2013 and plunged 83.79% in 2014, its largest moves.
- Tracing BHC's Curent Deferred Tax Liability over 5 years: stood at $4.4 million in 2011, then decreased by 0.79% to $4.4 million in 2012, then soared by 1398.98% to $66.0 million in 2013, then sank by 83.79% to $10.7 million in 2014, then advanced by 8.41% to $11.6 million in 2015.
- Business Quant data shows BHC's Curent Deferred Tax Liability at $11.6 million in Q3 2015, $38.2 million in Q2 2015, and $10.7 million in Q4 2014.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Curent Deferred Tax (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Bausch Health Companies | 1.66 Bn | 1.33 Bn | 2.52 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2015 | 11.60 Mn |
| Sep 30, 2015 | 11.60 Mn |
| Jun 30, 2015 | 38.20 Mn |
| Jun 30, 2015 | 38.20 Mn |
| Dec 31, 2014 | 10.70 Mn |
| Dec 31, 2014 | 10.70 Mn |
| Sep 30, 2014 | 19.00 Mn |
| Sep 30, 2014 | 19.00 Mn |
| Jun 30, 2014 | 11.00 Mn |
| Jun 30, 2014 | 11.00 Mn |
| Mar 31, 2014 | 10.80 Mn |
| Mar 31, 2014 | 10.80 Mn |
| Dec 31, 2013 | 66.00 Mn |
| Dec 31, 2013 | 66.00 Mn |
| Sep 30, 2013 | 64.19 Mn |
| Sep 30, 2013 | 64.19 Mn |
| Jun 30, 2013 | 4.36 Mn |
| Jun 30, 2013 | 4.36 Mn |
| Mar 31, 2013 | 4.29 Mn |
| Mar 31, 2013 | 4.29 Mn |